Actuate Therapeutics Inc
(ACTU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Cash Flows From Operating Activities | ||
| Net Income | -27,285 | -24,745 |
| Accounts payable and accrued liabilities | -1,501 | 1,291 |
| Other Working Capital | 1,100 | 2,573 |
| Other Operating Activity | 5,843 | -744 |
| Operating Cash Flow | $-21,843 | $-21,625 |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $N/A |
| Cash Flows From Financing Activities | ||
| Change In Short Term Borrowing | 200 | N/A |
| Debt Issued | 5,500 | N/A |
| Common Stock Issued | 23,957 | N/A |
| Other Financing Activity | -2,131 | 4,135 |
| Financing Cash Flow | $27,526 | $4,135 |
| Beginning Cash Position | 2,959 | 20,449 |
| End Cash Position | 8,642 | 2,959 |
| Net Cash Flow | $5,683 | $-17,491 |
| Free Cash Flow | ||
| Operating Cash Flow | -21,843 | -21,625 |
| Free Cash Flow | -21,843 | -21,625 |